Observational
Highlights the adverse prognosis of new-onset atrial fibrillation in chronic coronary syndrome patients and the need for improved management strategies.
May support closer monitoring in chronic coronary syndrome; extends observational data but leaves optimal interventions open.
Adverse prognosis of new-onset atrial fibrillation in patients with chronic coronary syndromes in the CLARIFY registry and possible approaches to improve their outcome. Abbreviations: AA, antiarrhythmic drugs; A-C HR, all-cause mortality hazard ratio; CA, catheter ablation; CCS, chronic coronary syndrome; CV HR, cardiovascular mortality hazard ratio; GDMT, guideline-directed medical therapy; HR, hazard ratio for adverse events, from left to right (dark box): stroke, myocardial infarction, hospitalization for heart failure, bleeding; NOAF, new-onset atrial fibrillation, SR, sinus rhythm.
No takes yet. Share an insight, caveat, or question.
Hatala et al. (2023) conducted an observational in chronic coronary syndromes. new-onset atrial fibrillation vs. sinus rhythm was evaluated on adverse prognosis. New-onset atrial fibrillation in patients with chronic coronary syndromes in the CLARIFY registry is associated with an adverse prognosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: